ESR1 and triple-negative breast carcinoma: Triple negative breast cancer (TNBC) is characterized by lack of expression of estrogen receptors (ER) and progesterone receptors (PR) and lack of overexpression or amplification of human epidermal growth factor 2 (HER2).